111 matches for your search in the start-up spotlight
rss
More hope for pregnancy: Ovo Labs secures 4 million pounds in start-up capital
05-May-2025
Founded in January 2025, Ovo Labs is a biotech company that has emerged from the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen (Germany). The company develops novel therapeutics to improve the quality of human eggs. The active compounds are designed to help women remain ...
Isomorphic Labs announces $600m external investment round
03-Apr-2025
Isomorphic Labs, an AI-first drug design and development company, announced it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation from GV, and follow-on capital from existing investor, Alphabet. Isomorphic Labs was founded ...
Life Science startup introduces a laboratory platform to automate the planning, culture, and analysis of complex 3D cell culture models
27-Mar-2025
mo:re, a German Life Science startup, has raised €2.3 million in seed funding to accelerate the commercialization of its lab platform for complex cell culture workflows. High-Tech Gründerfonds (HTGF) led the round, with participation from Innovationsstarter Fonds Hamburg (IFH), Gilson Inc., ...
Start-up prize for "EmbryoNet AI Technologies"
25-Mar-2025
Using artificial intelligence to revolutionize drug development is the aim of the start-up "EmbryoNet AI Technologies" led by Konstanz biologist Patrick Müller. Müller and his team have now been awarded the start-up prize by the Federal Ministry for Economic Affairs and Climate Action (BMWK) for ...
Shorten research and development time for cancer drugs from 3 years to 12 months and significantly reduce development costs
24-Mar-2025
The German-Swiss biotechnology start-up BioCopy has secured new capital of 8 million euros. This sum is an important step for the company on its mission to produce more effective cancer drugs in the shortest possible time and at significantly lower costs. The company is supported by a group of ...
Tumour-on-chip model supports preclinical drug development on pancreatic cancer
10-Mar-2025
The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer drug research in collaboration with the research team of Prof. Dr. Nicole Teusch at the Institute of Pharmaceutical Biology and Biotechnology at Heinrich Heine University ...
03-Mar-2025
Improving treatment recommendations for colorectal cancer patients: This is the aim of a collaborative project between the University of Bonn, the company ESQlabs and the University Hospital Bonn (UKB), funded by the Federal Ministry of Education and Research. "ISPOT-K" combines organoids derived ...
Project receiving 800,000 euros from the biomedical start-up incubator IBT Lower Saxony
24-Feb-2025
MHH project LuFex aims to develop a new inhalative treatment with a plant-based anti-fibrosis drug and is receiving 800,000 euros from the biomedical start-up incubator IBT Lower Saxony. Tissue damage can affect many organs and is responsible for about half of all deaths in industrialised ...
Dynamic42 and research partners present three-organ system to reduce animal testing
20-Feb-2025
Organ-on-chip specialist Dynamic42 and ESQlabs, experts in digital life sciences solutions, have successfully developed a three-organ system, in close collaboration with Consumer Health Division of Bayer, and the Placenta Lab at Jena University Hospital. The platform has the potential to ...
Drug candidate AC102 in the clinical phase
19-Feb-2025
There is currently no drug approved worldwide for the treatment of sudden hearing loss. However, preclinical and clinical phase-1-studies with the innovative drug candidate AC102 have been promising. AudioCure Pharma, a Berlin-based start-up supported by investors, is driving forward research and ...
